Orthorexia Nervosa in Postmenopausal Osteoporosis
ConditionOsteoporosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age55-75
SponsorBeylikduzu State Hospital
About this trial
A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information regarding the duration of osteoporosis diagnosis, current treatments, history of fractures, history of falls, comorbidities, and smoking status will be collected. Femoral neck and L1-L4 T-scores and bone mineral density values obtained from existing DXA scans will be documented. Orthorexia nervosa-related symptoms will be assessed using the ORTO-11 scale, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and body image will be assessed using the Body Appreciation Scale-2.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women between 55-75 years
Women diagnosed with osteoporosis based on DXA measurements performed within the past six months.
Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls).
Willingness to participate and provision of written informed consent.
Disqualifiers
Refusal to participate in the study.
Diagnosed psychiatric disorders.
Cognitive impairment.
Presence of malignancy.
Trial population
The study population will consist of postmenopausal women with osteoporosis and age-matched healthy controls
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
ORTO-11 Scale
The ORTO-11 assesses orthorexic tendencies, which refer to an unhealthy obsession with healthy eating. It consists of 11 items rated on a 4-point Likert scale. Total scores range from 11 to 44, with lower scores indicating a higher risk of orthorexia nervosa.
Time frame
BaselineSecondary outcomes
1
Body Appreciation Scale-2 (BAS-2)
The BAS-2 assesses positive body image and appreciation of one's body. It consists of 10 items rated on a 5-point Likert scale (1 = Never, 5 = Always). Total scores range from 10 to 50, with higher scores indicating greater body appreciation.
Time frame
BaselineOther outcomes
1
Hospital Anxiety and Depression Scale (HADS)- Anxiety Score
The HADS-A subscale evaluates symptoms of anxiety. It consists of 7 items, each scored between 0 and 3. The total score ranges from 0 to 21, with higher scores indicating higher levels of anxiety.
Time frame
Baseline2
Hospital Anxiety and Depression Scale (HADS)- Depression Score
The HADS-D subscale evaluates symptoms of depression. It consists of 7 items, each scored between 0 and 3. The total score ranges from 0 to 21, with higher scores indicating higher levels of depression.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov